Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study.

Myriam DrysdaleEvgeniy R GalimovMarcus James YarwoodVishal PatelBethany LevickDaniel C GibbonsJonathan D WatkinsSophie YoungBenjamin F PierceEmily J LloydWilliam KerrHelen J BirchTahereh KamalatiStephen J Brett

Published in: BMJ open respiratory research (2024)

Risk of COVID-19 hospitalisation in sotrovimab-treated patients aged ≥65 years and with renal disease was significantly lower compared with untreated patients. Overall, risk of hospitalisation was also lower for sotrovimab-treated patients, but statistical significance was not reached.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
sars cov
peritoneal dialysis
coronavirus disease
tertiary care